Recommendation for the use of newly introduced Tdap vaccine in Korea / 소아과
Korean Journal of Pediatrics
;
: 141-145, 2011.
Article
Dans Anglais
| WPRIM
| ID: wpr-222095
ABSTRACT
Pertussis is an acute respiratory infection characterized by paroxysmal cough and inspiratory whoop for over 2 weeks. The incidence of pertussis has decreased markedly after the introduction of DTwP/DTaP vaccine, but the incidence of pertussis has increased steadily among young infant and among adolescents and adults in many countries. Td vaccine was used in this age group but the increase in pertussis has lead to the development of a Tdap vaccine. The Tdap vaccine is a Td vaccine with a pertussis vaccine added and is thought to decrease the incidence and transmission of pertussis in the respective age group. In Korea, two products are approved by the KOREA FOOD & DRUG ADMINISTRATION, which are ADACEL(TM) (Sanofi-Pasteur, Totonto, Ontario, Canada) and BOOSTRIX(R) (GlaxoSmithKline Biologicals, Rixensart, Belgium) for those aged between 11-64. This report summarizes the recommendations approved by the Committee on Infectious Diseases, the Korean Pediatric Society.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Ontario
/
Vaccin anticoquelucheux
/
Coqueluche
/
Maladies transmissibles
/
Incidence
/
Toux
/
Corée
Type d'étude:
Etude d'incidence
/
Étude pronostique
Limites du sujet:
Adolescent
/
Adulte
/
Adulte très âgé
/
Humains
/
Bébé
Pays comme sujet:
Amérique du Nord
/
Asie
langue:
Anglais
Texte intégral:
Korean Journal of Pediatrics
Année:
2011
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS